• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Sep;95(9):e29075.
doi: 10.1002/jmv.29075. Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant

Fabio Scarpa[SUP] 1 [/SUP], Stefano Pascarella[SUP] 2 [/SUP], Alessandra Ciccozzi[SUP] 3 [/SUP], Marta Giovanetti[SUP] 4 5 [/SUP], Ilenia Azzena[SUP] 1 6 [/SUP], Chiara Locci[SUP] 1 6 [/SUP], Marco Casu[SUP] 6 [/SUP], Pier Luigi Fiori[SUP] 1 7 [/SUP], Miriana Quaranta[SUP] 2 [/SUP], Eleonora Cella[SUP] 8 [/SUP], Daria Sanna[SUP] 1 [/SUP], Massimo Ciccozzi[SUP] 3 [/SUP]



Affiliations
Abstract

The severe acute respiratory syndrome coronavirus 2 EG.5 lineage is the latest variant under monitoring, and it is generating significant concern due to its recent upward trend in prevalence. Our aim was to gain insights into this emerging lineage and offer insights into its actual level of threat. Both genetic and structural data indicate that this novel variant presently lacks substantial evidence of having a high capacity for widespread transmission. Their viral population sizes expanded following a very mild curve and peaked several months after the earliest detected sample. Currently, neither the viral population size of EG.5 nor that of its first descendant is increasing. The genetic variability appear to be flattened, as evidenced by its relatively modest evolutionary rate (9.05 × 10[SUP]-4[/SUP] subs/site/year). As has been observed with numerous prior variants, attributes that might theoretically provide advantages seem to stem from genetic drift, enabling the virus to continually adjust to its host, albeit without a clear association with enhanced dangerousness. These findings further underscore the necessity for ongoing genome-based monitoring, ensuring preparedness and a well-documented understanding of the unfolding situation.

Keywords: EG.5; SARS-CoV-2; genetics; molecular epidemiology; phylodynamics; virus evolution.

 
Back
Top Bottom